Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Nebert

Showing results (1-10 of 350) with videos related to

Pageof 35
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1978
Genetic control of drug metabolismD W Nebert
Clinical Chemistry and Laboratory Medicine|November 30, 2000
Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicantsD W Nebert
British Medical Journal (Clinical Research Ed.)|August 22, 1981
Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolismD W Nebert
Biochemical Pharmacology|January 13, 1994
Drug-metabolizing enzymes in ligand-modulated transcriptionD W Nebert
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|March 1, 1991
Polymorphism of human CYP2D genes involved in drug metabolism: possible relationship to individual cancer riskD W Nebert
European Journal of Pharmacology|January 3, 2001
Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogeneticsD W Nebert
Journal of the National Cancer Institute|December 1, 1993
Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk?D W Nebert
The Journal of Biological Chemistry|February 10, 1970
Microsomal cytochromes b5 and P450 during induction of aryl hydrocarbon hydroxylase activity in mammalian cell cultureD W Nebert
Mutation Research|April 1, 1991
Role of genetics and drug metabolism in human cancer riskD W Nebert
EXS|January 1, 1994
Drug metabolism and signal transduction: possible role of Ah receptor and arachidonic acid cascade in protection from ethanol toxicityD W Nebert
Pageof 35

Showing results (1-10 of 350) with videos related to

Sort By:
Pageof 35
Advances in Experimental Medicine and Biology|January 1, 1978
Genetic control of drug metabolismD W Nebert
Clinical Chemistry and Laboratory Medicine|November 30, 2000
Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicantsD W Nebert
British Medical Journal (Clinical Research Ed.)|August 22, 1981
Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolismD W Nebert
Biochemical Pharmacology|January 13, 1994
Drug-metabolizing enzymes in ligand-modulated transcriptionD W Nebert
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|March 1, 1991
Polymorphism of human CYP2D genes involved in drug metabolism: possible relationship to individual cancer riskD W Nebert
European Journal of Pharmacology|January 3, 2001
Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogeneticsD W Nebert
Journal of the National Cancer Institute|December 1, 1993
Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk?D W Nebert
The Journal of Biological Chemistry|February 10, 1970
Microsomal cytochromes b5 and P450 during induction of aryl hydrocarbon hydroxylase activity in mammalian cell cultureD W Nebert
Mutation Research|April 1, 1991
Role of genetics and drug metabolism in human cancer riskD W Nebert
EXS|January 1, 1994
Drug metabolism and signal transduction: possible role of Ah receptor and arachidonic acid cascade in protection from ethanol toxicityD W Nebert
Pageof 35